Pharma & Biotech

While MiMedx shares recorded a modest decline of 1.8% in Friday's trading session, major institutional investors demonstrated continued conviction in...

A pair of significant analyst upgrades have generated renewed optimism for Zimmer Biomet Holdings, Inc., marking a potential turning point...

Biolife finds itself navigating turbulent waters as significant insider selling activity coincides with a mixed quarterly earnings report. The specialist...

While Ocugen's market performance has faced challenges, professional analysts are sending a decidedly different message. On Friday, Chardan Capital reaffirmed...

Cellectar Biosciences' stock registered modest gains in Monday's trading session, advancing 1.92% to reach $5.30. This upward movement coincided with...

Pharmaceutical leader Eli Lilly finds itself balancing ambitious growth initiatives with increased regulatory oversight. The company recently announced its largest...

Shares of healthcare distribution giant Cardinal Health showed signs of pressure as the trading week concluded. The stock's minor retreat...

Shares of telehealth company Hims & Hers Health came under significant selling pressure after the U.S. Food and Drug Administration...

Avanos Medical finds itself at a strategic crossroads as major institutional investors execute divergent moves following the medical technology company's...

The biotechnology sector is no stranger to dramatic price swings, but Century Therapeutics is currently weathering an exceptionally severe downturn....